Expression of the B7/BB1 Activation Antigen and its Ligand CD28 in T-Cell-Mediated Skin Diseases

• Published in: Journal of investigative dermatology Vol. 103; no. 4; pp. 539 - 543
• Main Authors: Simon, Jan C, Dietrich, Andrea, Mielke, Volker, Wuttig, Christiane, Vanscheidt, Wolfgang, Linsley, Peter S, Schöpf, Erwin, Sterry, Wolfram
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.1994
• Subjects: Antibodies, Monoclonal; B7-1 Antigen - physiology; BB1; Biopsy; CD28; CD28 Antigens - physiology; Dendritic Cells - immunology; Dermatitis, Allergic Contact - immunology; Dermatitis, Allergic Contact - pathology; Humans; Immune Tolerance; Immunity, Cellular; Keratinocytes - immunology; Ligands; Skin Diseases - immunology; T-Lymphocytes - immunology; CD28; BB1; B7
• ISSN: 0022-202X; 1523-1747
• DOI: 10.1111/1523-1747.ep12395743

Interactions of CD28 (on T cells) with its recently identified ligand B7/BB1 (on antigen-presenting cells) have been shown to activate T cells via a major histocompatibility complex/Ag-independent “alternative” pathway, leading to an amplification of T- cell – mediated immune responses. The in vivo relevance of these molecules for cutaneous immunity is presently unknown. These findings prompted us to study the expression of B7/BB1 and CD28 in normal human skin and in selected T-cell – mediated inflammatory skin diseases. Biopsies were obtained from lesional skin of patients with allergic contact dermatitis, lichen planus, and, as control, from basal cell carcinoma and from healthy controls. Serial cryostat sections were stained with a panel of MoAbs directed against CD28, B7/BB1, CD3, CD1a, and KiM8 using immunohistochemistry (ABC technique). CD28 expression was observed in the majority of dermal and epidermal CD3+ T cells in contact dermatitis and lichen planus. In normal skin and basal cell carcinoma, CD28 was expressed only occasionally by perivascular T cells. In allergic contact dermatitis and lichen planus, B7/BB1-expression was found on dermal dendritic cells, on dermal macrophages, on Langerhans cells, focally on keratinocytes, and occasionally on dermal T cells. No B7/BB1 immunoreactivity was detected in normal skin and basal cell carcinoma. These findings indicate that T-cell – mediated skin diseases are accompanied by an influx of CD28+ T cells and an upregulation of B7/BB1 on cutaneous antigen- presenting cells, keratinocytes, and on some T cells. We speculate that “alternative” T cell-activation via the B7/CD28 pathway may contribute to the pathogenesis of these skin diseases.